Longitudinal effect of olanzapine on fasting serum lipids: A randomized, prospective, 4-month study

Annals of the New York Academy of Sciences

Volumn 1032, Issue , 2004, Pages 295-296

  Kinon, Bruce J ^a   Liu Seifert, Hong ^a   Ahl, Jonna ^a   Ahmed, Saeeduddin ^a   Baker, Robert W ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Antipsychotics; Fasting serum lipids; Olanzapine; Risperidone; Schizophrenia

Indexed keywords

CHOLESTEROL; LIPID; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; TRIACYLGLYCEROL;

CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LONGITUDINAL STUDY; MENTAL DISEASE; PROSPECTIVE STUDY; PSYCHOSIS; RANDOMIZATION; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 14544293472     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1314.043     Document Type: Conference Paper

References (0)